2 results
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMOCompleted
Primary objective: To evaluate the effect of ravulizumab compared with placebo on amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R) score in adult patients with amyotrophic lateral sclerosis (ALS).Secondary objectives:1. To…